Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder that affects the cilia, the microscopic, hair-like structures that line the airways, ears, and other parts of the body. These cilia play a crucial role in moving mucus and other materials out of the respiratory tract, ensuring the proper functioning of the respiratory system. One specific form of this condition, PCD Type 19, is caused by mutations in the LRRC6 gene. Understanding the symptoms associated with this condition is crucial for early diagnosis and management. DNA Labs UAE offers a comprehensive genetic test for those who suspect they might be carriers or are showing symptoms of LRRC6 Gene Primary Ciliary Dyskinesia Type 19.
Symptoms of LRRC6 Gene Primary Ciliary Dyskinesia Type 19
The symptoms of LRRC6 Gene Primary Ciliary Dyskinesia Type 19 can vary widely among individuals but generally include a range of respiratory and sinus issues. These symptoms often present from birth or early childhood and can include:
- Chronic cough
- Recurrent chest infections
- Sinusitis
- Ear infections
- Situs inversus (a condition where the major visceral organs are reversed or mirrored from their normal positions)
- Infertility issues in adulthood due to impaired ciliary function in the reproductive organs
It is important to note that these symptoms can be indicative of other conditions as well, making genetic testing a valuable tool for accurate diagnosis.
Genetic Test for LRRC6 Gene Primary Ciliary Dyskinesia Type 19
DNA Labs UAE offers a genetic test specifically designed to diagnose mutations in the LRRC6 gene associated with Primary Ciliary Dyskinesia Type 19. This test is essential for individuals who exhibit the symptoms mentioned above or have a family history of the condition. The test is performed using a simple blood sample, making it a non-invasive procedure.
The cost of the LRRC6 Gene Primary Ciliary Dyskinesia Type 19 genetic test is 4400 AED. While the price may seem high, the value of a definitive diagnosis cannot be understated. It provides not only peace of mind but also a clear path forward for treatment and management of the condition.
Early diagnosis through genetic testing can significantly improve the quality of life for individuals with PCD Type 19. It allows for the implementation of targeted treatments and management strategies that can reduce the severity of symptoms and prevent complications.
Why Choose DNA Labs UAE?
DNA Labs UAE is a leading provider of genetic testing services in the United Arab Emirates. Our state-of-the-art laboratory is equipped with the latest technology to ensure accurate and reliable results. Our team of genetic experts is dedicated to providing personalized care and support throughout the testing process.
For more information about the LRRC6 Gene Primary Ciliary Dyskinesia Type 19 genetic test, or to schedule a consultation, please visit our website at DNA Labs UAE.
Understanding your genetic health is crucial for taking proactive steps towards managing your wellbeing. If you or a loved one is experiencing symptoms associated with Primary Ciliary Dyskinesia, consider the LRRC6 gene test. Early detection and diagnosis are key to effective management and treatment of this condition.
